Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA-587 is a small, non-coding RNA involved in post-transcriptional regulation of mRNA by binding to complementary sequences, predominantly in the 3'UTRs of target genes. In cancer biology, miR-587 is implicated in cell cycle progression, apoptosis regulation, migration, and invasion, with its roles being highly context-dependent. In colorectal cancer, miR-587 drives resistance to 5-fluorouracil-induced apoptosis by targeting PPP2R1B, leading to increased AKT signaling and decreased cell death. Conversely, in hepatocellular carcinoma, miR-587 functions as a tumor suppressor by targeting ribosomal protein SA (RPSA), inhibiting proliferation and invasion. Expression levels and functional roles of miR-587 are variable across tumor types, suggesting its utility as a biomarker for prognosis and therapy response, though its therapeutic targeting presents significant challenges due to its widespread effects and lack of clinical agents directly modulating this miRNA.
For 5-fluorouracil: miR-587 confers resistance by downregulating PPP2R1B, leading to AKT activation and reduced apoptosis. For AKT inhibitors (MK-2206): they overcome miR-587-mediated resistance by blocking downstream AKT phosphorylation. For experimental anti-miR oligonucleotides: they inhibit miR-587 to restore PPP2R1B expression and resensitize to chemotherapy.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA-587 (miR-587).